IL33 and type 2 diabetes mellitus: To investigate the pathophysiological relevance of IL-33 in vivo, we examined its activity in 2 distinct animal models that mechanistically represent type 1 diabetes and T2D, respectively: high-fat diet Streptozotocin and db/db uninephrectomized (unx).